Bain Capital Life Sciences Fund, L.P. - Significant Ownership

Signature - Title
/s/ Andrew Hack - Andrew Hack, Partner of Bain Capital Life Sciences Investors, LLC
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bain Capital Life Sciences Fund, L.P..

Significant Ownership of Bain Capital Life Sciences Fund, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XFOR X4 PHARMACEUTICALS, INC. Common Stock, par value $0.001 per share 9.99% $7.85M 2.44M Bain Capital Life Sciences Fund, L.P. Sep 9, 2025
ANNX Annexon, Inc. Common Stock, par value $0.001 per share 4.9% $7.24M 5.25M BCLS I Investco, LP Dec 31, 2024

Schedules 13D/G Reported by Bain Capital Life Sciences Fund, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.